Ticker Details
Vor Biopharma Inc. Common Stock
IPO Date:	February 1, 2021
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$562.59M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.40 | 4.61%
Avg Daily Range (30 D):	$0.61 | 4.21%
Avg Daily Range (90 D):	$0.79 | 5.31%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.82M
Avg Daily Volume (90 D):	1.37M

Trade Size
Avg Trade Size (Sh.):	53
Avg Trade Size (Sh.) (30 D):	89
Avg Trade Size (Sh.) (90 D):	92

Institutional Trades
Total Institutional Trades:	125
Avg Institutional Trade:	$2.2M
Avg Institutional Trade (30 D):	$1.05M
Avg Institutional Trade (90 D):	$1.46M
Avg Institutional Trade Volume:	.04M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$3.97M
Avg Closing Trade (30 D):	$1.44M
Avg Closing Trade (90 D):	$2.53M
Avg Closing Volume:	58.05K

News

Nov 11, 2025 @ 2:56 AM Vor Bio Announces Pricing of Public Offering of $1... Source: Vor Biopharma Inc.

Nov 8, 2025 @ 4:45 PM Telitacicept Achieved Primary Endpoint of Reducing... Source: Vor Bio

Oct 31, 2025 @ 8:30 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Carl Mauch And Sarah Spencer

Aug 18, 2025 @ 8:35 PM Vor Bio Reports Inducement Grants Under Nasdaq Lis... Source: Vor Bio

Jun 25, 2025 @ 8:50 PM Vor Bio Announces $175 Million Private Placement Source: Sarah Spencer

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-110.92	$-121.63	$-12.56
Diluted EPS	$-110.92	$-121.63	$-12.56
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-2449.55M	$-812.68M	$-1573.67M
Operating Income / Loss	$-366.99M	$-28.11M	$-274.28M
Cost of Revenue
Net Cash Flow	$105.42M	$-32.36M	$140.53M
PE Ratio

Splits
Sep 19, 2025	1:20